Clinical trial SGNPDL1V-001
A Phase 1 Study of SGN-PDL1V in Advanced Solid Tumors
| Organ | Multiple |
|---|---|
| Trial status | Trial open for recruitment |
| Investigator | |
| Trial type |
Interventional with experimental drug
|
| Phase | Trial phase 1 |
| Academic trial | Non |
| Sponsor | Seagen |
| EudraCT Identifier | 2021-003517-19 |
| ClinicalTrials.gov | https://clinicaltrials.gov/ct2/show/NCT05208762 |
| Last update |